0001493152-26-009689
SEC filingEvofem Biosciences, Inc. issued a press release on March 11, 2026, announcing its financial results. The filing includes Item 2.02 for results of operations and financial condition, Item 7.01 referencing Exhibit 99.2, and Item 9.01 listing Exhibits 99.1 and 99.2.